EUCTR2006-004423-11-ES进行中（未招募）不适用
An uncontrolled, open-label, titration, long-term safety (up to 12 months) and efficacy study of tamsulosin hydrochloride in children with neuropathic bladder, with a randomized pharmacokinetic sub-study investigating low, medium and high dose ranges
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 183
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
An uncontrolled, open-label, titration, long-term safety (up to 12 months) and efficacy study of tamsulosin hydrochloride in children with neuropathic bladder, with a randomized pharmacokinetic sub-study investigating low, medium and high dose rangeseurogenic BladderMedDRA version: 8.1Level: LLTClassification code 10029279Term: Neurogenic bladderEUCTR2006-004423-11-DEBoehringer Ingelheim Pharma GmbH & Co. KG100
进行中（未招募）
不适用
An uncontrolled, open-label, titration, long-term safety up to 12 months and efficacy study of tamsulosin hydrochloride in children with neuropathic bladder, with a randomized pharmacokinetic sub-study investigating low, medium and high dose ranges - NDeurogenic bladderMedDRA version: 9.1Level: LLTClassification code 10029279Term: Neurogenic bladderEUCTR2006-004423-11-ITBOEHRINGER ING.260
进行中（未招募）
1 期
An uncontrolled, open-label, titration, long-term safety (up to 12 months) and efficacy study of tamsulosin hydrochloride in children with neuropathic bladder, with a randomized pharmacokinetic sub-study investigating low, medium and high dose rangeseurogenic BladderMedDRA version: 8.1Level: LLTClassification code 10029279Term: Neurogenic bladderEUCTR2006-004423-11-BESCS Boehringer Ingelheim Comm.V100
进行中（未招募）
1 期
A study to assess safety, tolerability, and processing by the body of multiple doses of zosurabalpin administered through a tube inserted into a vein in the arm of healthy participantsISRCTN13481000F. Hoffmann-La Roche Ltd45
进行中（未招募）
1 期
A Multicentre Study to Evaluate the Safety and Efficacy of the Eye Implant ILUVIEN® in Children with non-infectious uveitis affecting the posterior segment of the eyeon-Infectious Uveitis affecting the posterior segmentMedDRA version: 20.1Level: LLTClassification code: 10036370Term: Posterior uveitis Class: 10021881CTIS2023-509469-19-00Alimera Sciences Europe Limited25